Breaking News Instant updates and real-time market news.

MBLX

Metabolix

$0.43

-0.045 (-9.47%)

16:11
10/17/16
10/17
16:11
10/17/16
16:11

Metabolix provides updates on strategic restructuring, cash position

Metabolix announced the management team that will lead Yield10 Bioscience. The company also provided an update on its strategic restructuring and cash position. In July, Metabolix announced a strategic restructuring under which Yield10 Bioscience is becoming the company's core business. In connection with the restructuring, the company is also working to rebrand itself as Yield10 Bioscience. Metabolix CEO Joseph Shaulson is stepping down from his current executive responsibilities and will provide transition support to the management team through the end of 2016. He will also remain on the company's board. Johan van Walsem, Metabolix COO, has been leading the wind down of the company's biopolymer operations and transfer of biopolymer assets to CJ CheilJedang. He is expected to leave the company at the end of October. The company previously announced plans to reduce staffing levels to approximately 20 people in connection with its strategic restructuring. Current headcount is 29 and is expected to reach the target level of approximately 20 during Q4 as activities related to the wind down of the company's biopolymer operations and transfer of biopolymer assets to CJ CheilJedang are completed. In connection with the wind down of biopolymer operations, Metabolix ceased pilot production of biopolymer materials and reached agreements with the owner-operators of its biopolymer pilot production facilities regarding the termination of these services. The company incurred cash restructuring costs of approximately $0.9M and issued 275,000 shares of common stock in Q3 related to these agreements and other restructuring activities. Remaining cash restructuring costs associated with the company's strategic restructuring are estimated at approximately $2.5M and are expected to be paid out over the next 12 to 24 months. Metabolix had approximately $9.7M in cash at September 30. The company currently estimates that its cash on hand together with expected cash receipts from its outstanding government research grants will be sufficient to support its operations into Q4 of 2017. This includes both the estimated cash operating cost of the Yield10 Bioscience business as well as remaining cash restructuring costs expected to be incurred during the period.

MBLX Metabolix
$0.43

-0.045 (-9.47%)

02/09/16
RODM
02/09/16
INITIATION
Target $3
RODM
Buy
Metabolix initiated with a Buy at Rodman & Renshaw
Rodman & Renshaw analyst Amit Dayal started Metabolix with a Buy rating and $3 price target.
02/09/16
02/09/16
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy imitations include: ANSYS (ANSS) initiated with an Overweight at Mitsubishi UFJ... Antero Midstream (AM) initiated with a Buy at Janney Capital... Autodesk (ADSK) initiated with a Neutral at Mitsubishi UFJ... Cheesecake Factory (CAKE) initiated with a Buy at Maxim... Depomed (DEPO) initiated with a Buy at UBS... Fleetmatics (FLTX) initiated with a Market Perform at Avondale... Glaukos (GKOS) initiated with an Overweight at Piper Jaffray... La Jolla (LJPC) initiated with an Outperform at Cowen... Manhattan Associates (MANH) initiated with a Market Perform at Avondale... Metabolix (MBLX) initiated with a Buy at Rodman & Renshaw... Opower (OPWR) initiated with an Outperform at Avondale... Social Reality (SCRI) initiated with a Buy at Rodman & Renshaw... Splunk (SPLK) initiated with an Overweight at Mitsubishi UFJ... Sucampo (SCMP) initiated with a Buy at UBS... Ultragenyx (RARE) initiated with a Buy at H.C. Wainwright... Workday (WDAY) initiated with an Overweight at Mitsubishi UFJ.

TODAY'S FREE FLY STORIES

INTU

Intuit

$119.08

0.32 (0.27%)

11:51
04/26/17
04/26
11:51
04/26/17
11:51
Options
Renewed interest in Intuit downside puts »

Renewed interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UA

Under Armour

$18.10

0.13 (0.72%)

, UAA

Under Armour

$19.51

-0.02 (-0.10%)

11:45
04/26/17
04/26
11:45
04/26/17
11:45
Earnings
On The Fly: What to watch in Under Armour earnings report »

Under Armour (UA, UAA) is…

UA

Under Armour

$18.10

0.13 (0.72%)

UAA

Under Armour

$19.51

-0.02 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

11:45
04/26/17
04/26
11:45
04/26/17
11:45
General news
Treasury Option Action: put selling on bonds »

Treasury Option Action:…

NADL

North Atlantic Drilling

$2.46

0.26 (11.82%)

11:44
04/26/17
04/26
11:44
04/26/17
11:44
Technical Analysis
North Atlantic Drilling spikes higher, retraces »

Shares are still up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$20.22

0.2 (1.00%)

11:44
04/26/17
04/26
11:44
04/26/17
11:44
Periodicals
Airbus confirms CEO under investigation by Vienna prosecutors, Reuters says »

Tom Enders, the CEO of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KATE

Kate Spade

$17.43

-0.07 (-0.40%)

11:41
04/26/17
04/26
11:41
04/26/17
11:41
Options
Notable call buyer in Kate Spade »

Notable call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:37
04/26/17
04/26
11:37
04/26/17
11:37
General news
2-Yr FRN Note Auction Bid/Cover data reported »

2-Yr FRN Note Auction…

11:36
04/26/17
04/26
11:36
04/26/17
11:36
General news
2-Yr FRN Note Auction Total Amount data reported »

2-Yr FRN Note Auction…

NADL

North Atlantic Drilling

$2.43

0.23 (10.45%)

11:34
04/26/17
04/26
11:34
04/26/17
11:34
Hot Stocks
North Atlantic Drilling jumps 12% after credit facility amended »

Earlier today, North…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWW

Grainger

$192.85

-0.51 (-0.26%)

11:31
04/26/17
04/26
11:31
04/26/17
11:31
Hot Stocks
Grainger raises dividend 5% to $1.28 per share »

W.W. Grainger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 19

    Jul

  • 17

    Oct

  • 24

    Jan

FCAU

Fiat Chrysler

$11.48

0.94 (8.92%)

11:31
04/26/17
04/26
11:31
04/26/17
11:31
Options
Fiat Chrysler option volume is 7X normal driven by a premium sale »

Fiat Chrysler option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$32.33

0.47 (1.48%)

, EVR

Evercore Partners

$75.30

-3.5 (-4.44%)

11:25
04/26/17
04/26
11:25
04/26/17
11:25
Periodicals
Volkswagen considering options for Ducati motorcycle brand, Reuters reports »

Volkswagen (VLKAY) has…

VLKAY

Volkswagen

$32.33

0.47 (1.48%)

EVR

Evercore Partners

$75.30

-3.5 (-4.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CGIX

Cancer Genetics

$4.15

-0.05 (-1.19%)

, TRPX

Therapix Biosciences

$7.30

-0.2 (-2.67%)

11:25
04/26/17
04/26
11:25
04/26/17
11:25
Conference/Events
RedChip to hold a virtual conference »

April Global Online…

CGIX

Cancer Genetics

$4.15

-0.05 (-1.19%)

TRPX

Therapix Biosciences

$7.30

-0.2 (-2.67%)

PBIO

Pressure BioSciences

$0.26

-0.03055 (-10.54%)

IDXG

Interpace Diagnostics

$2.43

0.09 (3.85%)

XRM

Xerium Technologies

$6.97

0.08 (1.16%)

ESES

Eco-Stim Energy

$1.09

-0.0001 (-0.01%)

AMMA

Alliance MMA

$1.40

-0.14 (-9.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 01

    May

INFO

IHS Markit

$43.76

-0.05 (-0.11%)

11:25
04/26/17
04/26
11:25
04/26/17
11:25
Conference/Events
IHS Markit to hold an investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

TRN

Trinity Industries

$27.60

0.84 (3.14%)

11:22
04/26/17
04/26
11:22
04/26/17
11:22
Hot Stocks
Trinity sees Q2 revenue for Inland Barge running at approx. 50% of Q1 levels »

Says "very little…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 01

    May

  • 09

    May

LN

LINE Corp.

$34.72

-2.8654 (-7.62%)

11:22
04/26/17
04/26
11:22
04/26/17
11:22
Downgrade
LINE Corp. rating change  »

Update: LINE Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$37.10

-0.115 (-0.31%)

11:21
04/26/17
04/26
11:21
04/26/17
11:21
Options
Defensive option play opened in the Brazil ETF »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
04/26/17
04/26
11:17
04/26/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGP

GGP

$22.36

-0.25 (-1.11%)

11:16
04/26/17
04/26
11:16
04/26/17
11:16
Options
General Growth put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 17

    May

$NYE

NYSE Market Internals

11:16
04/26/17
04/26
11:16
04/26/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LN

LINE Corp.

$34.75

-2.84 (-7.56%)

11:15
04/26/17
04/26
11:15
04/26/17
11:15
Downgrade
LINE Corp. rating change  »

LINE Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$485.52

13.7602 (2.92%)

11:10
04/26/17
04/26
11:10
04/26/17
11:10
Hot Stocks
Battleground: Piper says buy Chipotle after earnings while RBC steps aside »

Shares of Chipotle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$180.73

-2.78 (-1.51%)

11:04
04/26/17
04/26
11:04
04/26/17
11:04
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing sees organic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 31

    May

MDSO

Medidata

$63.34

-0.31 (-0.49%)

11:02
04/26/17
04/26
11:02
04/26/17
11:02
Recommendations
Medidata analyst commentary  »

Medidata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

NUS

Nu Skin

$56.59

-0.52 (-0.91%)

11:02
04/26/17
04/26
11:02
04/26/17
11:02
Downgrade
Nu Skin rating change  »

Nu Skin downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.